Practice Facilitation for Pediatric Suicide Prevention
This study is testing a program called "Practice Facilitation" to help primary care doctors better use the National Institute of Mental Health (NIMH) Youth Suicide Prevention Pathway. This pathway helps doctors find and support young people at risk for suicide. The study will provide 6 months of Practice Facilitation, which includes reviewing clinic data and offering support, along with a 2-hour training on the NIMH pathway. The goal is to see if this support helps clinics use the suicide prevention pathway more effectively and reduces youth suicide. You could be eligible if you are between 12 and 80 years old. The study aims to enroll 360 participants. We don't know the current recruitment status.
- Study design
- This interventional study plans to enroll 360 participants. It is not specified if it is randomized or blinded.
- What's involved
- Youth participants will complete questionnaires at the beginning and after 6 months. Providers will participate in 6 months of practice facilitation and training.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 6 months after enrollment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Practice Facilitation to Enhance Implementation of a Pediatric Suicide Prevention Pathway
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Bruno J Anthony, PhD · PRINCIPAL_INVESTIGATOR · University of Colorado School of Medicine - Anschutz Medical Campus
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Ask Suicide Screening QuestionsAt enrollment (baseline) and 6 months (study completion)
A set of four brief suicide screening questions that takes 20 seconds to administer. A validated tool that is approved for use by the Joint Commission for all ages
- Suicidal Ideation QuestionnaireAt enrollment (baseline) and 6 months (study completion)
The Suicidal Ideation Questionnaire (SIQ) assesses the frequency of suicidal ideation.The SIQ consists of 30 items and is appropriate for students in Grades 10-12. The Suicidal Ideation Questionnaire-Junior (SIQ-JR) consists of 15 items and is designed for students in Grades 7-9, consists of a subset of items from the original SIQ. For both the SIQ and SIQ-Jr, the stem indicates "Listed below are a number of sentences about thoughts that people sometimes have. Each item has 7 response options ranging from 0 ("I never had this thought") to 6 ("almost every day"). Scoring is done by summing the item response scores for a range of 0 to 180 for the SIQ and 0 to 90 for the SIQ-JR, with higher scores indicating the presence of more symptomatology.
- Patient Health Questionnaire-9At enrollment (baseline) and 6 months (study completion)
A 9- item measure that assesses the severity of depressive disorders and episodes (or clinically significant symptoms of depressive disorders and episodes) in children ages 11-17. It was adapted from Patient Health Questionnaire-9 modified for Adolescents (PHQ-A\]). Possible range of scores is 0 to 27, with the higher scores indicating the presence of more symptomatology. Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively.
- Center for Epidemiological Studies Depression Scale (CES-D)At enrollment (baseline) and 6 months (study completion)
Center for Epidemiological Studies Depression Scale (CES-D) is a 20-item self-report scale that measures the severity of depression symptoms over the past week. The scale can be used by individuals between the ages of 6 to 17. Possible range of scores is 0 to 60, with the higher scores indicating the presence of more symptomatology.